We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
5.4
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
2.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1226
MGIC Investment
MTG
$5.68B
| $757K | ﹤0.01% |
27,175
+3,649
| +16% | +$93.9K |
2014 Q2
44 quarters
|
|
1227
NETGEAR
NTGR
$600M
| $755K | ﹤0.01% |
25,957
-44,856
| -63% | -$1.2M |
2024 Q1
5 quarters
|
|
1228
Tennant Co
TNC
$1.13B
| $754K | ﹤0.01% |
9,730
-2,171
| -18% | -$160K |
2020 Q2
20 quarters
|
|
1229
Autoliv
ALV
$8.46B
| $743K | ﹤0.01% |
6,639
-131
| -2% | -$12.8K |
2023 Q1
9 quarters
|
|
1230
RingCentral
RNG
$6.49B
| $739K | ﹤0.01% |
26,054
-579
| -2% | -$14.9K |
2022 Q4
10 quarters
|
|
1231
Cognizant
CTSH
$29.5B
| $738K | ﹤0.01% |
9,453
+7,279
| +335% | +$558K |
2013 Q2
48 quarters
|
|
1232
Boeing
BA
$148B
| $731K | ﹤0.01% |
3,488
-36,585
| -91% | -$6.91M |
2013 Q2
48 quarters
|
|
1233
Worthington Enterprises
WOR
$3.12B
| $726K | ﹤0.01% |
11,414
+17
| +0.1% | +$942 |
2025 Q1
1 quarter
|
|
1234
Globus Medical
GMED
$10.5B
| $724K | ﹤0.01% |
12,267
-361
| -3% | -$23.3K |
2016 Q4
34 quarters
|
|
1235
Middleby
MIDD
$4.89B
| $719K | ﹤0.01% |
4,995
-101
| -2% | -$14.2K |
2018 Q3
27 quarters
|
|
1236
JBS N.V.
JBS
$42.4B
| $713K | ﹤0.01% |
+48,827
| New | +$687K |
2025 Q2
0 quarters
|
|
1237
Louisiana-Pacific
LPX
$4.81B
| $710K | ﹤0.01% |
8,252
-88
| -1% | -$7.82K |
2013 Q2
48 quarters
|
|
1238
Crocs
CROX
$5.99B
| $708K | ﹤0.01% |
6,994
-30
| -0.4% | -$3.06K |
2017 Q3
31 quarters
|
|
1239
DELISTED
Masimo
MASI
| $707K | ﹤0.01% |
4,201
-46,801
| -92% | -$7.47M |
2015 Q3
39 quarters
|
|
1240
Commerce Bancshares
CBSH
$7.92B
| $705K | ﹤0.01% |
11,902
-236
| -2% | -$13.8K |
2013 Q2
48 quarters
|
|
1241
Xometry
XMTR
$5.51B
| $699K | ﹤0.01% |
20,673
-16,598
| -45% | -$487K |
2024 Q4
2 quarters
|
|
1242
Digital Realty Trust
DLR
$63.2B
| $696K | ﹤0.01% |
3,995
-13
| -0.3% | -$2.13K |
2013 Q3
47 quarters
|
|
1243
Puma Biotechnology
PBYI
$545M
| $694K | ﹤0.01% |
202,335
+1,373
| +0.7% | +$4.38K |
2016 Q2
36 quarters
|
|
1244
DELISTED
Synovus
SNV
| $689K | ﹤0.01% |
13,313
-390
| -3% | -$17.9K |
2013 Q2
48 quarters
|
|
1245
Consolidated Edison
ED
$40.6B
| $688K | ﹤0.01% |
6,852
-3,067
| -31% | -$325K |
2013 Q2
48 quarters
|
|
1246
Toro Company
TTC
$9.47B
| $687K | ﹤0.01% |
9,717
+189
| +2% | +$13.4K |
2015 Q3
39 quarters
|
|
1247
SOPHiA GENETICS
SOPH
$605M
| $682K | ﹤0.01% |
220,000
+31,000
| +16% | +$92.4K |
2022 Q4
10 quarters
|
|
1248
Prestige Consumer Healthcare
PBH
$2.34B
| $681K | ﹤0.01% |
8,530
-660
| -7% | -$55.2K |
2016 Q1
37 quarters
|
|
1249
Churchill Downs
CHDN
$5.72B
| $681K | ﹤0.01% |
6,743
-217
| -3% | -$21.2K |
2016 Q2
36 quarters
|
|
1250
Privia Health
PRVA
$2.82B
| $675K | ﹤0.01% |
29,352
-376
| -1% | -$8.71K |
2022 Q3
11 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.